UroGen Pharma Ltd. said Chaim Hurvitz resigned from the company's board of directors.
The Nasdaq-listed company also appointed Mark Schoenberg as its chief medical officer.
Schoenberg served as a consultant to UroGen since 2013 before becoming the company's medical director in 2015.
